Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$21.54 - $24.41 $36,251 - $41,082
-1,683 Reduced 35.56%
3,050 $69,000
Q2 2023

Aug 14, 2023

SELL
$12.62 - $24.47 $30,565 - $59,266
-2,422 Reduced 33.85%
4,733 $115,000
Q1 2023

May 09, 2023

BUY
$12.98 - $17.1 $1,622 - $2,137
125 Added 1.78%
7,155 $96,000
Q4 2022

Feb 10, 2023

BUY
$13.92 - $17.0 $97,398 - $118,949
6,997 Added 21203.03%
7,030 $110,000
Q3 2022

Nov 10, 2022

SELL
$13.36 - $16.75 $23,513 - $29,480
-1,760 Reduced 98.16%
33 $0
Q2 2022

Aug 15, 2022

BUY
$12.69 - $19.25 $1,433 - $2,175
113 Added 6.73%
1,793 $26,000
Q1 2022

May 12, 2022

BUY
$15.5 - $23.89 $4,960 - $7,644
320 Added 23.53%
1,680 $30,000
Q4 2021

Feb 14, 2022

BUY
$20.04 - $23.84 $16,653 - $19,811
831 Added 157.09%
1,360 $32,000
Q3 2021

Nov 15, 2021

BUY
$17.38 - $21.54 $9,194 - $11,394
529 New
529 $11,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.